4.8 Article

m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer

Journal

THERANOSTICS
Volume 11, Issue 5, Pages 2201-2217

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/thno.52717

Keywords

Colon cancer; m(6)A modification; Tumor microenvironment; Immune profiles; Immunotherapy

Funding

  1. Key Research and Development Program of Shandong Province [2019JZZY010104, 2019GSF108146]
  2. Academic promotion programme of Shandong First Medical University [2019QL021]
  3. Special Foundation for Taishan Scholars Program of Shandong Province [ts20190978]
  4. Research Incubation Funding of Shandong Provincial Hospital

Ask authors/readers for more resources

Recent studies have shown that m(6)A modification is significantly associated with TME diversity, and different m(6)A modification patterns in colon cancer are correlated with distinct clinical outcomes and biological pathways.
Recent studies have highlighted the biological significance of RNA N-6-methyladenosine (m(6)A) modification in tumorigenicity and progression. However, it remains unclear whether m(6)A modifications also have potential roles in immune regulation and tumor microenvironment (TME) formation. Methods: In this study, we curated 23 m(6)A regulators and performed consensus molecular subtyping with NMF algorithm to determine m(6)A modification patterns and the m(6)A-related gene signature in colon cancer (CC). The ssGSEA and CIBERSORT algorithms were employed to quantify the relative infiltration levels of various immune cell subsets. An PCA algorithm based m(6)Sig scoring scheme was used to evaluate the m(6)A modification patterns of individual tumors with an immune response. Results: Three distinct m(6)A modification patterns were identified among 1307 CC samples, which were also associated with different clinical outcomes and biological pathways. The TME characterization revealed that the identified m(6)A patterns were highly consistent with three known immune profiles: immune-inflamed, immune-excluded, and immune-desert, respectively. Based on the m(6)Sig score, which was extracted from the m(6)A-related signature genes, CC patients can be divided into high and low score subgroups. Patients with lower m(6)Sig score was characterized by prolonged survival time and enhanced immune infiltration. Further analysis indicated that lower m(6)Sig score also correlated with greater tumor mutation loads, PD-L1 expression, and higher mutation rates in SMGs (e.g., PIK3CA and SMAD4). In addition, patients with lower m(6)Sig scores showed a better immune responses and durable clinical benefits in three independent immunotherapy cohorts. Conclusions: This study highlights that m(6)A modification is significantly associated with TME diversity and complexity. Quantitatively evaluating the m(6)A modification patterns of individual tumors will strengthen our understanding of TME characteristics and promote more effective immunotherapy strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available